| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/09/2004 | CN1503801A Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino [2,3-f] quinoxaline |
| 06/09/2004 | CN1503800A antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7h-[1,4] dioxino [2,3-3] indole |
| 06/09/2004 | CN1503799A Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza cyclopenta [A] naphthalene |
| 06/09/2004 | CN1503798A Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused- [1,4]-derivatives of oxaheterocycle-fused-[1,4]-benzodioxans |
| 06/09/2004 | CN1503793A N-substituted nonabyl-heterocyclic nmda/nrzb antagonists |
| 06/09/2004 | CN1503792A Phthalazinones derivatives useful as pde 4/7 inhibtors |
| 06/09/2004 | CN1503790A Heterocyclic sulfonamide inhibitors of beta amyloid production |
| 06/09/2004 | CN1503787A Novel compounds |
| 06/09/2004 | CN1503784A 2-lminopyrrolidine derivatives |
| 06/09/2004 | CN1503781A Process for the preparatino of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 06/09/2004 | CN1503774A Carboxylic acid derivative and thereof |
| 06/09/2004 | CN1503672A 6-substituted pyrido-pyrimidines |
| 06/09/2004 | CN1503667A Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 06/09/2004 | CN1503666A Carbamate compounds for use in preventing or treating bipolar disorder |
| 06/09/2004 | CN1503665A Carbamate compounds for sue in preventing or treating anxiety disorders |
| 06/09/2004 | CN1503663A Film coating |
| 06/09/2004 | CN1502697A Alzhimer's disease secretase |
| 06/09/2004 | CN1502696A Alzheimer's disease secretase |
| 06/09/2004 | CN1502692A Alzheimer's disease secretase |
| 06/09/2004 | CN1502628A Polyglycol modification article for acidic fibroblast growth factor and its mutant |
| 06/09/2004 | CN1502616A Method for the preparation of citalopram |
| 06/09/2004 | CN1502612A Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/09/2004 | CN1502362A Traditional Chinese medicine for tranquilization |
| 06/09/2004 | CN1502359A Prunella spike oral liquid and preparation process thereof |
| 06/09/2004 | CN1502353A Compound chuanxiong and angelica total extract and preparation, use thereof |
| 06/09/2004 | CN1502345A Medicine for treating paralysis disease |
| 06/09/2004 | CN1152880C Process for preparation of oxymorphone, oxycodone and derivatives |
| 06/09/2004 | CN1152877C Piperazine derivatives |
| 06/09/2004 | CN1152874C Antipsychotic 4 (1 H-indolyl-1-YL)-1-substituted piperidine derivatives |
| 06/09/2004 | CN1152871C Hydroxylamine derivative useful for enhancing molecular chaperon prodn. and the prep. thereof |
| 06/09/2004 | CN1152864C Phenylphenanthridines with PDE-IV inhibiting activity |
| 06/09/2004 | CN1152863C Substituted pyridines as selective coclooxygenase-2-inhibitors and composition thereof |
| 06/09/2004 | CN1152857C Phenylsulfonamide-phenylethylamines useful as dopamine receptors |
| 06/09/2004 | CN1152706C Chinese medicine for treating epilepsy |
| 06/09/2004 | CN1152701C Kidney-benefiting and tranquilizing medicine and its prepn |
| 06/09/2004 | CN1152700C Capsule for treating nervous headache an dpreparation process thereof |
| 06/09/2004 | CN1152699C Medicine for treating and preventing senile dementia |
| 06/09/2004 | CN1152679C Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agent |
| 06/09/2004 | CN1152677C Treatment of spasticity, convulsions by isovaleric acid derivatives CNS |
| 06/08/2004 | US6747151 Azo compounds for type I phototherapy |
| 06/08/2004 | US6747061 N-substituted dithiocarbamates for the treatment of biological disorders |
| 06/08/2004 | US6747057 Such 1-(2-bromo-4,5-dichloro-thiophen-3-yl)-2-chloro-ethanone for treatment of alzheimer's disease or diabetes |
| 06/08/2004 | US6747043 Alkoxy aryl β2 adrenergic receptor agonists |
| 06/08/2004 | US6747042 N-heterocyclic derivatives useful for treating or preventing neuronal damage associated with neurological disease |
| 06/08/2004 | US6747035 Antiinflammatory agents; antiallergens |
| 06/08/2004 | US6747034 CRF receptor antagonists and methods relating thereto |
| 06/08/2004 | US6747032 Pyrimidin-4-one compounds |
| 06/08/2004 | US6747031 N-heterocyclic derivatives as NOS inhibitors |
| 06/08/2004 | US6747030 Cis-6-(3,5-dimethylpiperazin-1-yl)-5-methoxy-1-(2'-methyl-4'-( 5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-carbonyl)indoline, its hydrochloride salt, or another pharmaceutically acceptable salt thereof; antidepressants |
| 06/08/2004 | US6747029 Dopamine D4 receptor antagonists as treatment for attention deficit-hyperactivity disorder |
| 06/08/2004 | US6747026 NK-1 receptor active amine oxide prodrugs |
| 06/08/2004 | US6747024 Inhibiting calpain and/or reactive oxygen species in warm-blooded animals |
| 06/08/2004 | US6747004 Contacting embryonic forebrain cells in vitro with amount of endometrial bleeding associated factor protein having specified amino acid sequence effective to induce proliferation of forebrain cells |
| 06/08/2004 | US6746689 Intradermal-penetration agents for topical local anesthetic administration |
| 06/08/2004 | CA2307552C Substituted pyridine compounds as anti-inflammatory agents |
| 06/08/2004 | CA2262884C Egf-like factor from chromaffin granules and glia cell-derived neurotrophic factor with survival-promoting activity on daergic neurons |
| 06/03/2004 | WO2004046348A1 Methods, nucleic acid constructs and cells for treating neurodegenerative disorders |
| 06/03/2004 | WO2004046152A1 Diazinopyrimidines |
| 06/03/2004 | WO2004046146A1 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 06/03/2004 | WO2004046136A1 Pyrazine compounds as crf modulators |
| 06/03/2004 | WO2004046132A1 4-tetrazolyl-4phenylpiperidine derivatives for treating pain |
| 06/03/2004 | WO2004046130A1 Pyridazinone derivatives as cdk2-inhibitors |
| 06/03/2004 | WO2004046124A1 Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders |
| 06/03/2004 | WO2004046117A1 Pyridazinone derivatives as gsk-3beta inhibitors |
| 06/03/2004 | WO2004046116A1 Novel process for the preparation of imidazolyl compounds |
| 06/03/2004 | WO2004046113A2 Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors |
| 06/03/2004 | WO2004046094A1 Histone deacetylase inhibitors |
| 06/03/2004 | WO2004045651A1 Compounds which can be used to diagnose and monitor diseases associated with the formation of amyloid protein fibrils |
| 06/03/2004 | WO2004045638A1 Vanilloid receptor-2 ligands for treating anxiety or depression |
| 06/03/2004 | WO2004045599A1 Therapeutic delivery of carbon monoxide |
| 06/03/2004 | WO2004045592A2 Compounds and methods for increasing neurogenesis |
| 06/03/2004 | WO2004045589A1 Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders |
| 06/03/2004 | WO2004045584A1 Bupropion hydrochloride solid dosage forms |
| 06/03/2004 | WO2004045536A2 Method and compositions for temporarily incapaciting subjets |
| 06/03/2004 | WO2004045533A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/03/2004 | WO2004045518A2 Open chain prolyl urea-related modulators of androgen receptor function |
| 06/03/2004 | WO2004035037A3 Derivatives of n-phenylanthranilic acid and 2-benzimidazolon as potassium channel and/or cortical neuron activity modulators |
| 06/03/2004 | WO2004033448A3 Isolation, purification and synthesis of procyanidin b2 and uses thereof |
| 06/03/2004 | WO2004026286A3 Selective phosphodiesterase 9a inhibitors as medicaments for improving cognitive processes |
| 06/03/2004 | WO2004009549A3 Piperidines useful for the treatment of central nervous system disorders |
| 06/03/2004 | WO2004006830A3 Use of ccn protein family members for the treatment of disorder associated to an altered calcium and/or sodium flux |
| 06/03/2004 | WO2003102183A9 Pramyxovirus vectors encoding antibody and utilization thereof |
| 06/03/2004 | WO2003091260A9 Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof |
| 06/03/2004 | WO2003089619A3 Placental derived stem cells and uses thereof |
| 06/03/2004 | WO2003088761A3 Physiologically compatible, phospholipid-containing, stable and hard matrix |
| 06/03/2004 | WO2003086371A3 Use of ep4 receptor ligands in the treatment of il-6 involved diseases |
| 06/03/2004 | WO2003084937A3 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases |
| 06/03/2004 | WO2003079025A3 Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof |
| 06/03/2004 | WO2003063800A8 8-heteroaryl xanthine adenosine a2b receptor antagonists |
| 06/03/2004 | WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase |
| 06/03/2004 | WO2003048153A8 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers |
| 06/03/2004 | WO2003045369A3 Use of l isomers of amino acid derivatives of hydroxyguanidine for producing no, pharmaceutical compositions containing same and pharmaceutical uses |
| 06/03/2004 | WO2003039598A8 Selective norepinephrine serotonin reuptake inhibitors for treating fibromyalgia syndrome, chronic fatique syndrome and pain |
| 06/03/2004 | WO2003032995A8 Rosuvastatin in pre demented states |
| 06/03/2004 | WO2002070457A8 Inhibitor of monoamine uptake |
| 06/03/2004 | US20040107453 Multipotent adult stem cells, sources thereof, methods of obtaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 06/03/2004 | US20040106800 cannabinoid (cb1); treating disorders involving cannabinoid neurotransmission |
| 06/03/2004 | US20040106794 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/03/2004 | US20040106778 Interferon gamma-like protein |
| 06/03/2004 | US20040106683 show selectivity to the MC1 and MC4 melanocortin receptors as agonists and/or antagonists |